Approval · Notice of Compliance 17090 · 2015
TEVA-INDAPAMIDE: Notice of Compliance 17090
Issued July 14, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17090
- Date
- July 14, 2015
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Diuretic, antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-INDAPAMIDE | 02231184 | Cancelled Post Market |
Medicinal ingredients
- INDAPAMIDE 2.5 MG per TAB